The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Big data in oncology: Challenges and solutions.
 
Neil J. Shah
Honoraria - MedNet, LLC; MedNet, LLC; MJH Life Sciences
Consulting or Advisory Role - Exelixis; Graticule; Merck Sharp & Dohme Corp.
Research Funding - Aravive (Inst); Exelixis
Travel, Accommodations, Expenses - Merck
 
Nadia Bahadur
No Relationships to Disclose
 
Andrew Niederhausern
No Relationships to Disclose
 
Alysha Insinga
No Relationships to Disclose
 
Ibrahim Shah
No Relationships to Disclose
 
Gianna West
No Relationships to Disclose
 
Hamza Ahmad
No Relationships to Disclose
 
Sene Martin
No Relationships to Disclose
 
Adam Watson
Stock and Other Ownership Interests - Johnson & Johnson; Pfizer
 
Chelsea Nichols
No Relationships to Disclose
 
Jasme Lee
No Relationships to Disclose
 
Samantha Brown
Research Funding - AACR (Inst)
 
Jonathan E. Rosenberg
Honoraria - Clinical Care Options; EMD Serono; Medscape; MJH Life Sciences; Peerview; Pfizer; Physicans' Education Resource; Research To Practice; UpToDate
Consulting or Advisory Role - Alligator Bioscience; Astellas Pharma; AstraZeneca/MedImmune; Bayer; BioClin Therapeutics; Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Hengrui Pharmaceutical; Immunomedics; Imvax; Infinity Pharmaceuticals; Janssen Oncology; Lilly; Merck; Mirati Therapeutics; Pfizer/EMD Serono; Pharmacyclics; QED Therapeutics; Roche/Genentech; Seagen; Tyra Biosciences
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); QED Therapeutics (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Predictor of platinum sensitivity (Inst)
 
Michael Moran
No Relationships to Disclose
 
Gregory J. Riely
Research Funding - Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Rain Therapeutics (Inst); Rain Therapeutics (Inst); Roche/Genentech (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Patent application submitted covering pulsatile use of erlotinib to treat or prevent brain metastases (Inst)
Travel, Accommodations, Expenses - Bayer; Merck
Other Relationship - Mirati Therapeutics; Pfizer; Roche/Genentech; Takeda
 
Katherine Panageas
Stock and Other Ownership Interests - 23andMe; Adicet Bio; Chinook Therapeutics; Codexis; T2 Biosystems; Vincerx Pharma
Research Funding - AACR (Inst)
 
Peter D. Stetson
No Relationships to Disclose
 
Theodora Bakker
No Relationships to Disclose
 
John Philip
No Relationships to Disclose